Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies DOI Creative Commons
Noha Ryad, Ayman Abo Elmaaty, Samy Selim

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(46), P. 34005 - 34026

Published: Jan. 1, 2024

Cancer is the second leading cause of death globally, surpassed only by heart disease. Moreover, bacterial infections remain a significant global health burden, contributing substantially to morbidity and mortality, especially among hospitalized patients. EGFR has emerged as prime therapeutic target due its pivotal role in driving uncontrolled cell growth survival across numerous cancer types. In addition, DNA gyrase represents promising for development novel antimicrobial agents. Therefore, we aimed design synthesize new multi-target quinoline hybrids (7-17e) capable acting anti-proliferative agents inhibiting microbial gyrase, respectively. The inhibitory potential synthesized compounds was determined using

Language: Английский

Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors DOI Creative Commons
Hany M. Abd El‐Lateef,

Ahmed Gaafar Ahmed Gaafar,

Arwa Sultan Alqahtani

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(34), P. 24781 - 24790

Published: Jan. 1, 2024

A set of novel quinoline tethered cis -vinyl triamides derivatives has been designed, synthesized and screened for in vitro cytotoxicity against the MCF-7 breast adenocarcinoma cell line.

Language: Английский

Citations

3

Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK DOI Creative Commons
Hany M. Abd El‐Lateef, Duaa Bafail,

Noura Hamdi Yousef Alhalees

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(32), P. 23495 - 23504

Published: Jan. 1, 2024

A sequence of novel 2-(quinoline-4-carbonyl)hydrazide scaffolds carrying the acrylamide moiety have been synthesized and evaluated for in vitro cytotoxicity against an MCF-7 breast cancer cell line.

Language: Английский

Citations

2

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking DOI Creative Commons
Heba Abdelmegeed,

Lina M. A. Abdel Ghany,

Amira Youssef

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(31), P. 22092 - 22112

Published: Jan. 1, 2024

A series of quinoline derivatives was designed and synthesized as novel tubulin inhibitors targeting the colchicine binding site.

Language: Английский

Citations

1

Novel Quinolin-4-ylcarbonylhydrazine Having N-(3-Arylacryloyl) Moiety: Design, Synthesis and Biological Evaluation as Potential Cytotoxic Agents against MDA-MB-231 via Tubulin Assembly Inhibition DOI
Hany M. Abd El‐Lateef,

Tahani H. Alharbi,

Eman Fayad

et al.

Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1321, P. 140214 - 140214

Published: Sept. 27, 2024

Language: Английский

Citations

1

Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies DOI Creative Commons
Noha Ryad, Ayman Abo Elmaaty, Samy Selim

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(46), P. 34005 - 34026

Published: Jan. 1, 2024

Cancer is the second leading cause of death globally, surpassed only by heart disease. Moreover, bacterial infections remain a significant global health burden, contributing substantially to morbidity and mortality, especially among hospitalized patients. EGFR has emerged as prime therapeutic target due its pivotal role in driving uncontrolled cell growth survival across numerous cancer types. In addition, DNA gyrase represents promising for development novel antimicrobial agents. Therefore, we aimed design synthesize new multi-target quinoline hybrids (7-17e) capable acting anti-proliferative agents inhibiting microbial gyrase, respectively. The inhibitory potential synthesized compounds was determined using

Language: Английский

Citations

0